| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.9M | -9.6% | -21.2% |
| Cost of Revenue | $2.7M | -18.2% | -21.3% |
| Gross Profit | $4.2M | -2.8% | -21.2% |
| R&D Expense | $172K | +100.0% | -29.2% |
| SG&A Expense | $2.7M | -8.3% | -27.3% |
| Operating Income | -$1.2M | +47.3% | +29.0% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.1M | +18.6% | +0.2% |
| Accounts Receivable | $3.5M | -12.9% | -21.1% |
| Inventory | $3.1M | -5.5% | +11.4% |
| Current Assets | $14.3M | +3.6% | -10.1% |
| Total Assets | $30.7M | -0.0% | -23.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$1.2M | — | — |
| Financing Cash Flow | $2.2M | — | — |
| Free Cash Flow | -$3.7M | — | — |
| — |
| Net Income | -$1.6M | +34.8% | +23.6% |
| EPS (Basic) | -$0.36 | +40.0% | +32.1% |
| EPS (Diluted) | -$0.36 | +40.0% | +32.1% |
| $15.0M |
| +7.3% |
| +7.0% |
| Long-term Debt | $15.3M | +2.1% | +2.1% |
| Total Liabilities | $29.4M | -3.3% | -4.7% |
| Stockholders' Equity | $1.3M | +326.6% | -85.9% |